< Back to latest news & events

Event

IPBC Connect 2020

September 2020

Event date: 10th September 2020

IAM’s IPBC Connect virtual event will be held across the month of September and HGF is proud to be a sponsor.

IPBC Connect is specifically designed for IP business leaders and it will include more than 45 individual interactive digital sessions, purpose-built to facilitate discussion, benchmarking and the sharing of best practice in key areas of strategic IP value creation.

HGF Partners Kate Taylor and Dr Andrew Wells will be hosting a closed boardroom session ‘IP challenges in life sciences’ on 10th September. They will explore the key challenges facing life sciences and discuss best practices for overcoming them.

Find out more

Attendees

Kate
Taylor

Latest updates

Happy World IP Day!

This year’s theme is ‘IP and the SDGs: Building our common future with innovation and creativity’. At HGF we are committed to supporting our clients in sustainable technologies and routinely …

Read article

IP Ingredients, Part 12: Exploring colours in the food & drink sector – overcoming hurdles and leveraging colour trade marks

We will all recognise as consumers an instance of when we used the colour of a product or its packaging to identify a specific brand that we wanted to buy …

Read article

Medical 3D Technologies: From Scanning to Printing

When we think of 3D technologies, we often think of 3D printing, which, as discussed later, has seen rapid advances in recent years. However, a sometimes overlooked area of medical …

Read article

Opinion Piece: Unitary Patent and Unified Patent Court in Ireland

Intellectual Property (IP) is a core part of any business and particularly is a vital part of the strategic toolkit for any business that creates value through innovation and constant …

Read article

IP Ingredients Blog, Parts 11-20

Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink …

Read article

EnteroBiotix Limited Secures £27m Financing Round to Advance Clinical Trials

We are pleased to congratulate EnteroBiotix, on their milestone in their journey towards revolutionising healthcare for patients battling gut-related ailments. The leading clinical-stage biotechnology company has successfully closed a £27 …

Read article
See all updates